Abstract
The sigma-1 receptor is an enigmatic ER-resident transmembrane protein linked to a variety of human diseases. Although the receptor was first cloned 20 years ago, the molecular structure of the protein and the mechanistic basis for its interaction with drug-like small molecules have remained unclear until recently. The determination of the first crystal structure of human sigma-1 offered the first detailed views of the sigma-1 architecture, and revealed an unusual overall fold with a single transmembrane helix in each protomer. The structure shows an overall trimeric receptor arrangement, and each protomer binds a single ligand molecule at the center of its carboxy-terminal domain. These results offer detailed molecular views of receptor structure, oligomerization, and ligand recognition, providing a framework for the next era of sigma-1 research.
Authors (Assaf Alon, Hayden Schmidt, Sanduo Zheng) contributed equally and are listed in alphabetical order.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Su TP, Su TC, Nakamura Y, Tsai SY (2016) The sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharmacol Sci 37(4):262–278. doi:10.1016/j.tips.2016.01.003
Mavlyutov TA, Guo LW, Epstein ML, Ruoho AE (2015) Role of the sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS). J Pharmacol Sci 127:10–16. doi:10.1016/j.jphs.2014.12.013
Palmer CP, Mahen R, Schnell E, Djamgoz MB, Aydar E (2007) Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res 67:11166–11175. doi:10.1158/0008-5472.can-07-1771
Hayashi T, Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131:596–610. doi:10.1016/j.cell.2007.08.036
Balasuriya D, Stewart AP, Edwardson JM (2013) The sigma-1 receptor interacts directly with GluN1 but not GluN2A in the GluN1/GluN2A NMDA receptor. J Neurosci 33:18219–18224. doi:10.1523/jneurosci.3360-13.2013
Gao XF, Yao JJ, He YL, Hu C, Mei YA (2012) Sigma-1 receptor agonists directly inhibit Nav1.2/1.4 channels. PLoS One 7:e49384. doi:10.1371/journal.pone.0049384
Kim FJ et al (2010) Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding. Mol Pharmacol 77:695–703. doi:10.1124/mol.109.057083
Walker JM et al (1990) Sigma receptors: biology and function. Pharmacol Rev 42:355–402
Martin BR et al (1984) Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain. J Pharmacol Exp Ther 231:539–544
Fontanilla D et al (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323:934–937. doi:10.1126/science.1166127
Keiser MJ et al (2009) Predicting new molecular targets for known drugs. Nature 462:175–181. doi:10.1038/nature08506
Hanner M et al (1996) Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A 93:8072–8077
Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V (1996) Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 229:553–558. doi:10.1006/bbrc.1996.1842
Seth P, Leibach FH, Ganapathy V (1997) Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem Biophys Res Commun 241:535–540. doi:10.1006/bbrc.1997.7840
Seth P et al (1998) Cloning and functional characterization of a sigma receptor from rat brain. J Neurochem 70:922–931
Aydar E, Palmer CP, Klyachko VA, Jackson MB (2002) The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34:399–410
Laurini E et al (2011) Homology model and docking-based virtual screening for ligands of the sigma1 receptor. ACS Med Chem Lett 2:834–839. doi:10.1021/ml2001505
Ortega-Roldan JL, Ossa F, Amin NT, Schnell JR (2015) Solution NMR studies reveal the location of the second transmembrane domain of the human sigma-1 receptor. FEBS Lett 589:659–665. doi:10.1016/j.febslet.2015.01.033
Caffrey M, Li D, Dukkipati A (2012) Membrane protein structure determination using crystallography and lipidic mesophases: recent advances and successes. Biochemistry 51:6266–6288. doi:10.1021/bi300010w
Caffrey M, Cherezov V (2009) Crystallizing membrane proteins using lipidic mesophases. Nat Protoc 4:706–731
Smith JL, Fischetti RF, Yamamoto M (2012) Micro-crystallography comes of age. Curr Opin Struct Biol 22:602–612. doi:10.1016/j.sbi.2012.09.001
Chae PS et al (2010) Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins. Nat Methods 7:1003–1008. doi:10.1038/nmeth.1526
Gromek KA et al (2013) Improved expression and purification of sigma 1 receptor fused to maltose binding protein by alteration of linker sequence. Protein Expr Purif 89:203–209. doi:10.1016/j.pep.2013.03.013
Schmidt HR et al (2016) Crystal structure of the human sigma1 receptor. Nature 532:527–530. doi:10.1038/nature17391
Lever JR et al (2014) Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418. J Pharm Exp Ther 351:153–163. doi:10.1124/jpet.114.216671
John CS, Vilner BJ, Bowen WD (1994) Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells. J Med Chem 37:1737–1739
Knablein J et al (1997) Ta6Br(2+)12, a tool for phase determination of large biological assemblies by X-ray crystallography. J Mol Biol 270:1–7
Gromek KA et al (2014) The oligomeric states of the purified sigma-1 receptor are stabilized by ligands. J Biol Chem 289:20333–20344. doi:10.1074/jbc.M113.537993
Pal A et al (2007) Identification of regions of the sigma-1 receptor ligand binding site using a novel photoprobe. Mol Pharmacol 72:921–933. doi:10.1124/mol.107.038307
Mishra AK et al (2015) The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. Biochem J 466:263–271. doi:10.1042/bj20141321
Glennon RA et al (1994) Structural features important for sigma 1 receptor binding. J Med Chem 37:1214–1219
Seth P et al (2001) Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor. Biochim Biophys Acta 1540:59–67
Bermack JE, Debonnel G (2005) Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus. Synapse 55:37–44. doi:10.1002/syn.20085
Ablordeppey SY, Fischer JB, Law H, Glennon RA (2002) Probing the proposed phenyl-A region of the sigma-1 receptor. Bioorg Med Chem 10:2759–2765
Bowen WD, Hellewell SB, McGarry KA (1989) Evidence for a multi-site model of the rat brain sigma receptor. Eur J Pharmacol 163:309–318
Luty AA et al (2010) Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol 68:639–649. doi:10.1002/ana.22274
Ullah MI et al (2015) In silico analysis of SIGMAR1 variant (rs4879809) segregating in a consanguineous Pakistani family showing amyotrophic lateral sclerosis without frontotemporal lobar dementia. Neurogenetics 16:299–306. doi:10.1007/s10048-015-0453-1
Li X et al (2015) A SIGMAR1 splice-site mutation causes distal hereditary motor neuropathy. Neurology 84:2430–2437. doi:10.1212/wnl.0000000000001680
Al-Saif A, Al-Mohanna F, Bohlega S (2011) A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol 70:913–919. doi:10.1002/ana.22534
Gregianin E et al. (2016) Loss-of-function mutations in the SIGMAR1 gene cause distal hereditary motor neuropathy by impairing ER-mitochondria tethering and Ca2+ signalling. Hum Mol Genet. doi:10.1093/hmg/ddw220
Wong AY et al (2016) Aberrant subcellular dynamics of sigma-1 receptor mutants underlying neuromuscular diseases. Mol Pharmacol 90:238–253. doi:10.1124/mol.116.104018
Lomize MA, Pogozheva ID, Joo H, Mosberg HI, Lomize AL (2012) OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res 40:D370–D376. doi:10.1093/nar/gkr703
Ashkenazy H et al (2016) ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res 44:W344–W350. doi:10.1093/nar/gkw408
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG (outside the USA)
About this chapter
Cite this chapter
Alon, A., Schmidt, H., Zheng, S., Kruse, A.C. (2017). Structural Perspectives on Sigma-1 Receptor Function. In: Smith, S., Su, TP. (eds) Sigma Receptors: Their Role in Disease and as Therapeutic Targets. Advances in Experimental Medicine and Biology, vol 964. Springer, Cham. https://doi.org/10.1007/978-3-319-50174-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-50174-1_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50172-7
Online ISBN: 978-3-319-50174-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)